U.S. Markets closed

BioMarin to Participate in Two Investor Conferences in October

Cantor Fitzgerald Global Healthcare Conference on October 1 in New York City

Leerink Partners Roundtable Series: Rare Disease & Oncology on October 2 in New York City

SAN RAFAEL, Calif., Sept. 19, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (BMRN), today announced that management will participate in two investor conferences this October.  To access the events that are accessible by live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors 

Media

Traci McCarty                       

Debra Charlesworth

BioMarin Pharmaceutical Inc. 

BioMarin Pharmaceutical Inc.

(415) 455-7558                         

(415) 455-7451

 

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-investor-conferences-in-october-300713237.html